1. Home
  2. AVTX vs ACNT Comparison

AVTX vs ACNT Comparison

Compare AVTX & ACNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • ACNT
  • Stock Information
  • Founded
  • AVTX 2011
  • ACNT 1945
  • Country
  • AVTX United States
  • ACNT United States
  • Employees
  • AVTX N/A
  • ACNT N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • ACNT Steel/Iron Ore
  • Sector
  • AVTX Health Care
  • ACNT Industrials
  • Exchange
  • AVTX Nasdaq
  • ACNT Nasdaq
  • Market Cap
  • AVTX 138.8M
  • ACNT 122.5M
  • IPO Year
  • AVTX 2015
  • ACNT N/A
  • Fundamental
  • Price
  • AVTX $13.50
  • ACNT $12.27
  • Analyst Decision
  • AVTX Strong Buy
  • ACNT
  • Analyst Count
  • AVTX 9
  • ACNT 0
  • Target Price
  • AVTX $30.14
  • ACNT N/A
  • AVG Volume (30 Days)
  • AVTX 451.4K
  • ACNT 65.8K
  • Earning Date
  • AVTX 11-06-2025
  • ACNT 11-11-2025
  • Dividend Yield
  • AVTX N/A
  • ACNT N/A
  • EPS Growth
  • AVTX N/A
  • ACNT N/A
  • EPS
  • AVTX N/A
  • ACNT N/A
  • Revenue
  • AVTX $441,000.00
  • ACNT $172,594,000.00
  • Revenue This Year
  • AVTX N/A
  • ACNT $22.72
  • Revenue Next Year
  • AVTX N/A
  • ACNT N/A
  • P/E Ratio
  • AVTX N/A
  • ACNT N/A
  • Revenue Growth
  • AVTX N/A
  • ACNT 33.04
  • 52 Week Low
  • AVTX $3.39
  • ACNT $9.00
  • 52 Week High
  • AVTX $16.00
  • ACNT $13.70
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 65.78
  • ACNT 42.05
  • Support Level
  • AVTX $12.41
  • ACNT $12.54
  • Resistance Level
  • AVTX $14.73
  • ACNT $13.00
  • Average True Range (ATR)
  • AVTX 0.94
  • ACNT 0.32
  • MACD
  • AVTX 0.13
  • ACNT -0.05
  • Stochastic Oscillator
  • AVTX 70.97
  • ACNT 0.00

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About ACNT Ascent Industries Co.

Ascent Industries Co is engaged in the chemical and metal industry. The group operates into two reportable segments namely the Specialty Chemicals and Tubular Products. The Tubular Products segment serves markets through pipe and tube and customers in the appliance, architectural, automotive, and commercial transportation, brewery, chemical, petrochemical, and other industries. The Specialty Chemicals segment produces specialty products for pulp and paper, coatings, adhesives, sealants, and elastomers (CASE), textile, automotive, household, and other industries. It manufactures welded pipe and tube, majorly from stainless steel, duplex, and nickel alloys. The company also produces specialty chemicals and dyes used in various end markets.

Share on Social Networks: